Onkoteraapia (Estonian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Onkoteraapia" in Estonian language version.

refsWebsite

Global rank Estonian rank

4cancer.gov

1,684^th place

1,186^th place

4doi.org

2^nd place

16^th place

4worldcat.org

5^th place

76^th place

4nih.gov

4^th place

14^th place

2europa.eu

68^th place

18^th place

2nature.com

234^th place

88^th place

1mayoclinic.org

1,610^th place

1,426^th place

1postimees.ee

3,149^th place

4^th place

1biospace.com

low place

1eestiarst.ee

low place

1,098^th place

1aacrjournals.org

8,869^th place

3,039^th place

aacrjournals.org

cancerres.aacrjournals.org

Vincent T. DeVita Jr., Edward Chu, A History of Cancer Chemotherapy, doi: 10.1158/0008-5472.CAN-07-6611, Cancer Res November 1, 2008 68;8643,Veebiversioon (vaadatud 30.07.2013)

biospace.com

"Global Top 10 Cancer Drugs By Sales 2021". BioSpace (Ameerika inglise). Vaadatud 21. jaanuaril 2023.

cancer.gov

"Neoadjuvant therapy". www.cancer.gov (inglise). 2011. Vaadatud 21. jaanuaril 2023.
"Cytostatic agent". www.cancer.gov (inglise). 2. veebruar 2011. Vaadatud 21. jaanuaril 2023.
"Cytotoxic agent". www.cancer.gov (inglise). 2. veebruar 2011. Vaadatud 21. jaanuaril 2023.
"Biological therapy". www.cancer.gov (inglise). 2011. Vaadatud 21. jaanuaril 2023.

doi.org

Marquart, John; Chen, Emerson Y.; Prasad, Vinay (1. august 2018). "Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology". JAMA oncology. 4 (8): 1093–1098. DOI:10.1001/jamaoncol.2018.1660. ISSN 2374-2445. PMC 6143048. PMID 29710180.
Kato, Shumei; Kim, Ki Hwan; Lim, Hyo Jeong; Boichard, Amelie; Nikanjam, Mina; Weihe, Elizabeth; Kuo, Dennis J.; Eskander, Ramez N.; Goodman, Aaron; Galanina, Natalie; Fanta, Paul T.; Schwab, Richard B.; Shatsky, Rebecca; Plaxe, Steven C.; Sharabi, Andrew (2. oktoober 2020). "Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy". Nature Communications (inglise). 11 (1): 4965. DOI:10.1038/s41467-020-18613-3. ISSN 2041-1723.
Birrer, Michael J.; Moore, Kathleen N.; Betella, Ilaria; Bates, Richard C. (1. juuni 2019). "Antibody-Drug Conjugate-Based Therapeutics: State of the Science". Journal of the National Cancer Institute. 111 (6): 538–549. DOI:10.1093/jnci/djz035. ISSN 1460-2105. PMID 30859213.
Dai, Xiaofeng; Mei, Yi; Cai, Dongyan; Han, Weidong (2019). "Standardizing CAR-T therapy: Getting it scaled up". Biotechnology Advances. 37 (1): 239–245. DOI:10.1016/j.biotechadv.2018.12.002. ISSN 1873-1899. PMID 30543841.

eestiarst.ee

"Kasvajate molekulaarse diagnostika ja molekulaarse kasvajakonsiiliumi lõimimine kliinilisse praktikasse - Eesti Arst - Eesti Arstide Liidu ajakiri". eestiarst.ee. Vaadatud 22. jaanuaril 2023.

europa.eu

ema.europa.eu

Euroopa Ravimiamet. "IMFINZI" (PDF). ema.europa.eu. Vaadatud 21.01.2023.
Euroopa Ravimiamet. "Rixathon" (PDF). ema.europa.eu. Vaadatud 21.01.2023.

mayoclinic.org

"Adjuvant therapy: Balance side effects with benefits". Mayo Clinic (inglise). Vaadatud 21. jaanuaril 2023.

nature.com

Kato, Shumei; Kim, Ki Hwan; Lim, Hyo Jeong; Boichard, Amelie; Nikanjam, Mina; Weihe, Elizabeth; Kuo, Dennis J.; Eskander, Ramez N.; Goodman, Aaron; Galanina, Natalie; Fanta, Paul T.; Schwab, Richard B.; Shatsky, Rebecca; Plaxe, Steven C.; Sharabi, Andrew (2. oktoober 2020). "Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy". Nature Communications (inglise). 11 (1): 4965. DOI:10.1038/s41467-020-18613-3. ISSN 2041-1723.
FROM THE FOLLOWING ARTICLE: Chemotherapy and the war on cancerBruce A. Chabner & Thomas G. Roberts, JrNature Reviews Cancer 5, 65–72 (January 2005) doi:10.1038/nrc1529,[1]

nih.gov

pubmed.ncbi.nlm.nih.gov

Marquart, John; Chen, Emerson Y.; Prasad, Vinay (1. august 2018). "Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology". JAMA oncology. 4 (8): 1093–1098. DOI:10.1001/jamaoncol.2018.1660. ISSN 2374-2445. PMC 6143048. PMID 29710180.
Birrer, Michael J.; Moore, Kathleen N.; Betella, Ilaria; Bates, Richard C. (1. juuni 2019). "Antibody-Drug Conjugate-Based Therapeutics: State of the Science". Journal of the National Cancer Institute. 111 (6): 538–549. DOI:10.1093/jnci/djz035. ISSN 1460-2105. PMID 30859213.
Dai, Xiaofeng; Mei, Yi; Cai, Dongyan; Han, Weidong (2019). "Standardizing CAR-T therapy: Getting it scaled up". Biotechnology Advances. 37 (1): 239–245. DOI:10.1016/j.biotechadv.2018.12.002. ISSN 1873-1899. PMID 30543841.

ncbi.nlm.nih.gov

Marquart, John; Chen, Emerson Y.; Prasad, Vinay (1. august 2018). "Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology". JAMA oncology. 4 (8): 1093–1098. DOI:10.1001/jamaoncol.2018.1660. ISSN 2374-2445. PMC 6143048. PMID 29710180.

postimees.ee

tervis.postimees.ee

Liis Velsker, Edetabel: ravimitööstuse 20 edukamat tulevikutoodet, 11. august 2014, veebiversioon (vaadatud 96.08.2015).

worldcat.org

Marquart, John; Chen, Emerson Y.; Prasad, Vinay (1. august 2018). "Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology". JAMA oncology. 4 (8): 1093–1098. DOI:10.1001/jamaoncol.2018.1660. ISSN 2374-2445. PMC 6143048. PMID 29710180.
Kato, Shumei; Kim, Ki Hwan; Lim, Hyo Jeong; Boichard, Amelie; Nikanjam, Mina; Weihe, Elizabeth; Kuo, Dennis J.; Eskander, Ramez N.; Goodman, Aaron; Galanina, Natalie; Fanta, Paul T.; Schwab, Richard B.; Shatsky, Rebecca; Plaxe, Steven C.; Sharabi, Andrew (2. oktoober 2020). "Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy". Nature Communications (inglise). 11 (1): 4965. DOI:10.1038/s41467-020-18613-3. ISSN 2041-1723.
Birrer, Michael J.; Moore, Kathleen N.; Betella, Ilaria; Bates, Richard C. (1. juuni 2019). "Antibody-Drug Conjugate-Based Therapeutics: State of the Science". Journal of the National Cancer Institute. 111 (6): 538–549. DOI:10.1093/jnci/djz035. ISSN 1460-2105. PMID 30859213.
Dai, Xiaofeng; Mei, Yi; Cai, Dongyan; Han, Weidong (2019). "Standardizing CAR-T therapy: Getting it scaled up". Biotechnology Advances. 37 (1): 239–245. DOI:10.1016/j.biotechadv.2018.12.002. ISSN 1873-1899. PMID 30543841.